Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

NADQ vs PNAS


NADQAmundi Core Nasdaq-100 Swap UCITS ETF Dist
LU2197908721 · Equity · United States · Large cap
PNASAmundi PEA Nasdaq-100 UCITS ETF S - Acc
FR001400ZGR7 · Equity · United States · Large cap
Open the interactive comparison on rebalix.com →

Comparison window: 3 Jun 20258 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 10 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixNADQ vs PNAS · report of 10 September 2026

The funds at a glance

From official issuer documents and the ESMA register
NADQLU2197908721Amundi Core Nasdaq-100 Swap UCITS ETF DistEquity · United States · Large cap
Declared index
NASDAQ-100 Notional Net Total Return Index
TER
0.22%
Transaction (KID)
0.00%
Fund size
1.1 mld EUR
Launch
10 Sept 2020
Currency
USD
Replication
Synthetic (swap)
Hedging
No
Holdings
246
Distributions 12m
1.06 USD
Effective 🇮🇹 rate
26.00%
PNASFR001400ZGR7Amundi PEA Nasdaq-100 UCITS ETF S - AccEquity · United States · Large cap
Declared index
NASDAQ-100 Notional Net Total Return Index
TER
0.30%
Transaction (KID)
0.00%
Fund size
19 mln EUR
Launch
3 Jun 2025
Currency
EUR
Replication
Synthetic (swap)
Hedging
No
Holdings
65
Distributions 12m
acc.
Effective 🇮🇹 rate

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
NADQ3y avg: +0.00%/anno
2025
−0.07%
2024
+0.01%
2023
+0.06%
2022
+0.01%
PNASn/d
not honestly computable
Rebalix · NADQ vs PNASsection 1 of 4
RebalixNADQ vs PNAS · report of 10 September 2026
NADQAmundi Core Nasdaq-100 Swap UCITS ETF Dist · LU2197908721 · Equity · United States · Large cap
PNASAmundi PEA Nasdaq-100 UCITS ETF S - Acc · FR001400ZGR7 · Equity · United States · Large cap

Performance over the period, in euro

From 3 Jun 2025 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10014099134133
In today’s purchasing power (net of Italy inflation)
10014099132131
NADQPNAS
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-5%-10%-15%-20%NADQPNAS2026trough NADQ: −11.6% · 30 Mar 2026trough PNAS: −11.1% · 30 Mar 2026
Filled area: NADQ; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
NADQ−11.6%30 Mar 202618 days165 days · back to break-even on 17 Apr 2026
PNAS−11.1%30 Mar 202618 days165 days · back to break-even on 17 Apr 2026
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-5%-10%-15%-20%NADQPNAS2026trough NADQ: −12.7% · 30 Mar 2026trough PNAS: −12.3% · 30 Mar 2026
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · NADQ vs PNASsection 2 of 4
RebalixNADQ vs PNAS · report of 10 September 2026
NADQAmundi Core Nasdaq-100 Swap UCITS ETF Dist · LU2197908721 · Equity · United States · Large cap
PNASAmundi PEA Nasdaq-100 UCITS ETF S - Acc · FR001400ZGR7 · Equity · United States · Large cap

Geographic composition

% of portfolio, from full declared holdings
NADQPNASUnited States95.9%23.3%Canada1.6%0.0%Sweden1.4%0.0%Netherlands0.8%20.0%Germany0.2%21.5%

Sector composition

GICS sectors, same sources and dates
NADQPNASInformation Technology39.2%17.9%Consumer Discretionary13.6%2.4%Health Care10.3%19.5%Financials10.1%18.1%Communication Services7.6%0.7%Industrials7.6%28.9%Consumer Staples3.6%1.6%Materials3.2%2.5%

Portfolio overlap

18 common holdings · ticker match on full official portfolios
25%50%75%100%Weight of common holdings in NADQ26.0%Weight of common holdings in PNAS13.3%Truly shared part (duplicated investment)8.3%
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 18 common holdings this gives 8.3%: buying both funds, roughly this share of your money buys the same stocks twice. Matching uses the ISIN of each security, as published by both issuers in their baskets.
Rebalix · NADQ vs PNASsection 3 of 4
RebalixNADQ vs PNAS · report of 10 September 2026

Full comparison table

"—" = not published by the source, never estimated
NADQAmundi Core Nasdaq-100 Swap UCITS ETF Dist · LU2197908721 · Equity · United States · Large cap
PNASAmundi PEA Nasdaq-100 UCITS ETF S - Acc · FR001400ZGR7 · Equity · United States · Large cap
MetricNADQPNASNote
Identity
CategoryEquity · United States · Large capEquity · United States · Large capRebalix engine classification
ReplicationSynthetic (swap)Synthetic (swap)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policydistributingaccumulating
Costs
TER0.22%0.30%from the KID
Transaction costs (KID)0.00%0.00%internal
All-in cost0.22%0.30%TER + transaction
Tracking difference (3a)+0.00%vs its OWN index
Performance in euro (ECB rates)
1 year+26.1%+25.9%
3 years+80.6%
5 years+97.4%
10 years— = series younger than the window
Risk · last 3 years
Volatility (ann.)+20.59%
Max drawdown−22.85%
Sharpe1.02risk-free = ECB MRO avg
Sortino1.50like Sharpe, downside only
Distributions (fund currency)
Frequencyannualaccumulating class
Distributions, last 12 months1.06 USDaccumulating classper share
Distribution yield0.34%accumulating class12 months / NAV
Last ex-date9 Dec 2025 · 1.06 USDaccumulating class
Italian taxation
Effective capital-gains rate26.00%white list, current half-year
Documents & exchanges
Listing venues85ESMA register
Borsa Italiana ticker
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~140 euro NADQ · ~190 euro PNAS. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · NADQ vs PNASsection 4 of 4